{"url_path":"/sec/entx/8-k/2026-07-16/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","accession_number":"0001178913-26-003510","cik":"0001638097","ticker":"ENTX","issuer_name":"Entera Bio Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1638097/0001178913-26-003510-index.html","primary_entity_key":"0001638097","primary_entity_name":"Entera Bio Ltd."},"word_count":110,"has_tables":true,"body_markdown":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.\n\nAt the Annual Meeting, the Company’s shareholders approved an amendment (the “Articles Amendment”) to the Company’s Amended and Restated Articles of Association (as amended, the “Articles”)\n\nto increase the number of authorized Ordinary Shares from 140,010,000 to 350,000,000. The Articles Amendment became effective upon approval by the Company’s shareholders at the Annual Meeting. The foregoing description of the Amendment is\nonly a summary and is qualified in its entirety by the full text of the Articles, which are filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated by reference in this Item 5.03."}